Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulatory Effects of a Cell Processing Device: Insights from Single Cell RNA Sequencing and Gene Set Enrichment Analysis.

bioRxiv : the preprint server for biology·2025
Same author

Use of the Selective Cytopheretic Device with Continuous Renal Replacement Therapy in Children: A Comparison of Contemporary Cohorts.

Blood purification·2025
Same author

Selective Cytopheretic Device Therapy in the Context of Extracorporeal Membrane Oxygenation.

Medicina (Kaunas, Lithuania)·2025
Same author

Regional Citrate Anticoagulation and Infectious Complications in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy.

Nephron·2025
Same author

Management dilemma in choosing evolving treatments in neutropenic septic shock.

Pediatric nephrology (Berlin, Germany)·2025
Same author

The Impact of the Selective Cytopheretic Device on Neutrophil-to-Lymphocyte Ratios and Hematological Parameters in Acute Kidney Injury: A Pooled Analysis.

Nephron·2025

Related Experiment Video

Updated: Jul 3, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

Tissue engineering of a bioartificial kidney.

D A Cieslinski1, H David Humes

  • 1University of Michigan and Veteran's Administration Medical Center, 2215 Fuller Road, Ann Arbor, Michigan 48105.

Biotechnology and Bioengineering
|March 25, 1994
PubMed
Summary
This summary is machine-generated.

Tissue engineering aims to create implantable bioartificial kidneys for kidney failure treatment. This involves developing devices to replicate the kidney

More Related Videos

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
10:23

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Published on: November 4, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
10:23

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Published on: November 4, 2022

Area of Science:

  • Biotechnology
  • Tissue Engineering

Background:

  • Kidney failure necessitates long-term therapeutic solutions.
  • Tissue engineering offers potential for creating implantable devices to replace organ function.

Purpose of the Study:

  • To explore the potential of tissue engineering for developing an implantable bioartificial kidney.
  • To outline the functional requirements for such a device.

Main Methods:

  • Conceptual development of devices for ultrafiltration and transport regulation.
  • Utilizing synthetic materials, biologic compounds, and cellular components.

Main Results:

  • Long-term ex vivo therapy for kidney failure has been achieved.
  • The kidney is a potential first solid organ for tissue engineering replacement therapy.

Conclusions:

  • An implantable bioartificial kidney requires devices mimicking glomerular ultrafiltration and tubular transport.
  • Initial concepts for these essential devices are under development.